About Hospital Pediatrico de Coimbra
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bial - Portela C S.A.
1
BioMarin Pharmaceutical
1
Clementia Pharmaceuticals Inc.
1
Kyowa Kirin Pharmaceutical Development Ltd
1
Pfizer
1
Takeda
1
Clinical Trials at Hospital Pediatrico de Coimbra
During the past decade, Hospital Pediatrico de Coimbra conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase 4 Two Dose Level Study of Naglazyme(TM) (Galsulfase) in Infants With MPS VI
2006-05-01
2009-04-01
Completed
4
Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children
2007-12-07
2017-08-24
Completed
304
A Study of Dexlansoprazole in Healing and Maintenance of Healed Erosive Esophagitis (EE) in Children
2023-03-31
2027-11-17
Not yet recruiting
76
Registry for Patients With X-Linked Hypophosphatemia
2017-09-12
2029-07-01
Active, not recruiting
1,236
An Efficacy and Safety Study of Palovarotene for the Treatment of MO
2018-03-22
2020-10-30
Terminated
193
Observational Study Investigating Clinical & Anthropometric Characteristics of Children With Achondroplasia.
2018-06-15
2023-01-13
Completed
315
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hospital Pediatrico de Coimbra" #1 sponsor was "Bial - Portela C S.A." with 1 trials, followed by "BioMarin Pharmaceutical" with 1 trials
sponsored, "Clementia Pharmaceuticals Inc." with 1 trials sponsored, "Kyowa Kirin Pharmaceutical Development Ltd" with 1 trials sponsored and "Pfizer"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
Clinical Trials Conditions at Hospital Pediatrico de Coimbra
According to Clinical.Site data, the most researched conditions in "Hospital Pediatrico de Coimbra" are
"Achondroplasia" (1 trials), "Erosive Esophagitis" (1 trials), "Exostoses, Multiple Hereditary" (1 trials), "Maroteaux-Lamy Syndrome" (1 trials) and "Mucopolysaccharidosis VI" (1 trials). Many other conditions were trialed in "Hospital Pediatrico de Coimbra" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Pediatrico de Coimbra
Most popular intervention types in "Hospital Pediatrico de Coimbra" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Dexlansoprazole" (1 trials), "Eslicarbazepine acetate" (1 trials), "Eslicarbazepine acetate (BIA 2-093)" (1 trials), "Naglazyme" (1 trials) and "Palovarotene 2.5 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Pediatrico de Coimbra
The vast majority of trials in "Hospital Pediatrico de Coimbra" are
6 trials for "All" genders.
Clinical Trials Status at Hospital Pediatrico de Coimbra
Currently, there are NaN active trials in "Hospital Pediatrico de Coimbra".
1 are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Hospital Pediatrico de Coimbra,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Pediatrico de Coimbra, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".